BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine The post NICE says yes to BeiGene’s...
Biomind Labs Inc. (NEO: BMND | OTC: BMNDF | FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat...
Havn said it is actively seeking new funding, but it might not be successful. The post Havn Life Sciences Faces Bankruptcy, Cash Crunch Cuts Runway appeared...
In addition to California, Oregon & Washington state hot spots, at least 21 other states are stepping up discussions about decriminalization. The post...
PITTSBURGH, Sept. 21, 2022 – Simple computer-based neurocognitive training—using positive words and pictures designed to boost self-worth—prolongs...
Growing your own mushrooms can be intimidating, especially if it’s your first time. Yet, microdosing mushrooms or using them for other health purposes...
A sierra town in Mexico has become a unique tourist destination for people who want to get high on shrooms. But not all the locals are...
The article MindMed Doses First Patients in Phase 1 MDMA Trial was originally published on Microdose. MindMed Collaborators Dose First Subject in Phase...
Xpira Pharmaceuticals is one step closer to commercializing a treatment for anorexia that uses psilocybin. The post Psilocybin For Anorexia Gets FDA Study...
The psychedelic drug startup industry isn't blowing up quite the way industry watchers expected. But startups in the space that aren't drug related are...